Skip to main content

Bank of New York Mellon Corp

Bank

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1390777 NEW YORK, NY

Position in AVBP

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,610,561
+$1,869,977 QoQ
Shares Held
103,931
+37.8% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. AVBP ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,610,561 103,931
2026-03-31 $1,740,584 75,448
2025-12-31 $1,470,993 73,111
2025-09-30 $1,167,570 63,283
2025-06-30 $1,279,597 58,778
2025-03-31 $1,261,479 68,225
2024-12-31 $1,811,599 68,003
2024-09-30 $1,605,543 68,321
2024-06-30 $553,660 29,847
2024-03-31 $405,546 22,707